Top Story

Institution Spotlight: Bioresorbable vascular scaffolds at forefront of investigation at Cleveland Clinic

Institution Spotlight: Bioresorbable vascular scaffolds at forefront of investigation at Cleveland Clinic
May 29, 2016

Researchers at the Cleveland Clinic have been at the forefront of investigations into a promising new update to stent technology — the bioresorbable vascular scaffold.
Stephen G. Ellis, MD, director of interventional cardiology and senior academic officer for cardiology at Cleveland Clinic and co-primary investigator for the ABSORB III trial, told Cardiology Today’s Intervention. “Every year, 2% to 3% of patients have an adverse event related to the stent, and that risk seems to go on indefinitely as best we can tell. So, for the average 60-year-old — and that’s about the average age of people who receive stents — if they’re going to live another 20 years, there is a 50/50 chance they are going to have a bad outcome related to that stent over their lifetime.”

Ellis spoke with Cardiology Today’s Intervention about this ongoing risk for adverse events, the use of bioresorbable scaffolds to mitigate this risk and current research on these devices.

Meeting News CoverageVideo

VIDEO: CT-derived FFR shows promise in suspected ACS, warrants further investigation

May 28, 2016
CHICAGO — Maros Ferencik, MD, PhD, of the Oregon Health & Science University in Portland, offers investigator insight on non-invasive fractional flow reserve…
In the Journals

Percutaneous mitral valve implantation effective in patients with failed mitral bioprosthesis

May 27, 2016
Researchers conducted a retrospective study of 48 patients who underwent percutaneous transfemoral antegrade transseptal implantation of the Sapien, Sapien XT or Sapien…
In the Journals

Preoperative anemia increases mortality risk after surgery for CLI

May 27, 2016
Patients with critical limb ischemia are at greater immediate- and long-term risk for death after surgery if they have anemia before undergoing treatment, according to…
Meeting News Coverage

Flu vaccination may reduce dementia risk in patients with HF

May 27, 2016
Patients with HF who receive the influenza vaccination have a 35% reduced risk for dementia, according to new data presented at Heart Failure 2016 and the 3rd World…
More News Headlines »